GTP-dependent Binding of ADP-ribosylation Factor to Coatomer in Close Proximity to the Binding Site for Dilysine Retrieval Motifs and p23*

Liyun ZhaoDagger , J. Bernd HelmsDagger §, Josef Brunner, and Felix T. WielandDagger

From Dagger  Biochemie-Zentrum Heidelberg, University of Heidelberg, Im Neuenheimer Feld 328, 69120 Heidelberg, Germany and  Laboratorium für Biochemie, ETH Zürich, Universtitätstrasse 16, CH-8092 Zürich, Switzerland

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

A site-directed photocross-linking approach was employed to determine components that act downstream of ADP-ribosylation factor (ARF). To this end, a photolabile phenylalanine analog was incorporated at various positions of the putative effector region of the ARF molecule. Depending on the position of incorporation, we find specific and GTP-dependent interactions of ARF with two subunits of the coatomer complex, beta -COP and gamma -COP, as well as an interaction with a cytosolic protein (~185 kDa). In addition, we observe homodimer formation of ARF molecules at the Golgi membrane. These data suggest that the binding site of ARF to coatomer is at the interface of its beta - and gamma -subunits, and this is in close proximity to the second site of interaction of coatomer with the Golgi membrane, the binding site within gamma -COP for cytosolic dibasic/diphenylalanine motifs.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

COPI1-coated vesicles transport proteins and lipids between intracellular compartments along the secretory pathway (1, 2). The initial step in the formation of these vesicles involves the recruitment of two factors from the cytosol to the Golgi membrane; ADP-ribosylation factor (ARF) binds to Golgi membranes in a GTP-dependent manner (3-5) with subsequent recruitment of coatomer, a soluble complex of seven subunits (COPs) (6, 7).

Coatomer has a KKXX-COOH binding site (8), capable of binding both the dibasic ER retrieval motifs and the diphenylalanine motifs of members of the p24 family of proteins (9, 10). Conflicting data have been obtained concerning the binding site(s) of these motifs within coatomer. Using an affinity column containing a KKXX sequence, a coatomer subcomplex of alpha -, beta '-, and xi -COP could be isolated (8, 11). The diphenylalanine motif was shown to bind to beta -, gamma - and xi -COP (9). However, using direct photolabeling of intact coatomer with various photolabile peptides containing the dibasic and diphenylalanine motifs, only the gamma -COP subunit was labeled, suggesting that coatomer has only one binding site for the various types of these motifs (12, 13). The diphenylalanine sequence is present in the C-terminal tails of the members of p24 family of type I membrane proteins (9, 10, 14), and it has been proposed that one or more members of this family provide(s) a matrix for coatomer binding to Golgi membranes and subsequent formation of COPI-coated vesicles (10).

We previously used a site-directed photocross-linking approach to elucidate components that interact directly with ARF1 during coat assembly (15). This method is based on the replacement of an endogenous amino acid with a photolabile analog of phenylalanine, L-4'-(3-trifluoromenthyl-3H-diazirin-3-yl)phenyalanine ((Tmd)Phe) (16, 17). It was found that this analog in position 82 of ARF1 directly and exclusively interacts with the beta -COP subunit of coatomer during the formation of transport vesicles (15). Thus, it was inferred that a bivalent interaction of coatomer with Golgi membranes via ARF and via members of the p24 family of proteins is involved in the budding of a COPI-coated vesicle (15).

ARF, however, has been implicated in several other biochemical reactions such as activation of phospholipase D (18, 19) and interaction with heterotrimeric G proteins (20, 21) and biologically active phospholipids (22). To determine whether ARF interacts with additional effector molecules, we inserted the (Tmd)Phe analog at various positions of the putative effector loop of ARF, identified in its crystal structure and based on its similarity with Ras (23). We find that, depending on the site of insertion, the effector loop of ARF interacts with beta -COP, gamma -COP, and an as yet unidentified protein of ~185 kDa. In addition, evidence is presented that ARF is capable of forming a homodimer on Golgi membranes, the function of which remains to be determined.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Synthesis of Site-specific Photolabile ARF Mutants-- For details, refer to Zhao et al. (15). In short, the codon of the ARF cDNA corresponding to the amino acid position of interest was replaced with amber stop codon using the QuickChange site-directed mutagenesis kit from Stratagene. Amber suppressor tRNA, charged chemically with the photolabile amino acid (Tmd)Phe, was synthesized as described (16, 17). In vitro transcription using T7 RNA polymerase was performed with linearized plasmids according to the manufacturer's protocol. In vitro translation using Flexi-lysate (Promega) was performed in the presence of [35S]methionine and 5 µM suppressor tRNA at 30 °C for 2 h. The suppression efficiency was analyzed by SDS-PAGE (24) and subsequent autoradiography.

Irradiation of the Photolabile ARF Mutants-- 20 µl of the in vitro translation samples (performed as described above) was incubated in 25 mM Hepes/KOH (pH 7.2), 2.5 mM Mg(OAc)2, 20 mM KCl, 1 mg/ml ovalbumin, 1 mM dithiothreitol, 0.2 M sucrose, and 50 µM nucleotide (GDPbeta S or GTPgamma S) in the presence or absence of isolated CHO Golgi membranes, of purified rabbit liver coatomer, of recombinant mARF1, and of isolated bovine brain cytosol as described in the figure legends in a total volume of 500 µl for 15 min at 37 °C. After incubation the Golgi membranes were pelleted in a microcentrifuge (30 min at 14,000 rpm at 4 °C) and resuspended in 20 µl of 25 mM Hepes/KOH (pH 7.2), 20 mM KCl, 2.5 mM Mg(OAc)2, and 0.2 M sucrose. Samples were irradiated at 366 nm for 2 min on ice, and thereafter the membranes were pelleted in a microcentrifuge and analyzed by SDS-PAGE and sequent autoradiography. When no membranes were present during the incubation, the total volume of incubation was 50 µl and these samples were not subjected to centrifugation but rather the complete incubation subjected to irradiation. Golgi membranes from Chinese hamster ovary cells and bovine brain cytosol were isolated as described by Beckers et al. (25), coatomer was purified as described by Waters et al. (26) with modifications according to Pavel et al. (27), and recombinant mARF1 was produced and purified as described by Weiss et al. (28) and modified according to Helms et al. (29).

Antibodies and Immunoprecipitation-- In case the proteins were denatured prior to immunoprecipitation, SDS was added to a final concentration of 1% and the samples (20 µl) were incubated for 3 min at 95 °C. For immunoprecipitation, the samples were incubated with the indicated antibodies in 200 µl of 20 mM Tris-HCl (pH 7.5), 2 mM EDTA, 0.15 M NaCl, and 0.5% Triton X-100 (immunoprecipitation buffer) for 2 h at 4 °C by head-over-head rotation. If SDS was present in the sample, the amount of Triton X-100 was increased to 0.9% to have a 10-fold excess of Triton X-100 over SDS. Subsequently the samples were incubated with protein A-Sepharose (Amersham Pharmacia Biotech) for 2 h at 4 °C by head-over-head rotation. The beads were washed five times in immunoprecipitation buffer and once in phosphate-buffered saline. The precipitated material was solubilized in sample buffer and analyzed by Western blotting and autoradiography. For immunoprecipitation of native coatomer complex, anti-beta '-COP antibodies were used (30), and for immunoprecipitation of dissociated coatomer, antibodies against the respective individual subunits were used (against alpha -COP (31), beta -COP (32), beta '-COP (30), and gamma -COP (12)). The same antibodies were also used for analysis by Western blotting. For visualization the enhanced chemiluminescence system (Amersham Pharmacia Biotech) was used.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

In order to analyze proteins or molecules that act downstream of ARF (effector molecules), we focused on beta -sheet beta 2 (amino acids 41-46) and loop L4 (amino acids 47-50) (23). These structures constitute the putative effector region in ARF, based on its similarity with the Ras proteins, as revealed by a comparison of the crystal structure of ARF and Ras (23). The following criteria were applied for selection of amino acids to be replaced with the photolabile (Tmd)Phe: (i) insertion of the photolabile residue should not change the net charge of the ARF molecule and (ii) the amino acid to be replaced should have an optimal orientation (i.e. facing outward from the ARF molecule) for optimal cross-link efficiencies. Based on these criteria, we choose Val-43, Ile-46, and Ile-49 to be replaced with (Tmd)Phe, resulting in ARF mutants designated ARF-(Tmd)Phe-43, ARF-(Tmd)Phe-46, and ARF-(Tmd)Phe-49, respectively.

The photolabile ARF molecules were generated by mutating the corresponding codons of ARF1 cDNA to amber and subsequent in vitro transcription and translation with suppression of this stop codon by addition of suppressor tRNA chemically loaded with the photolabile amino acid analog (see "Experimental Procedures"). Translation in the presence of [35S]methionine allows visualization of the corresponding photolabile full-length protein by SDS-PAGE and autoradiography. Each mutated and radiolabeled ARF showed a GTP-dependent binding to Golgi membranes, excluding the possibility that replacement of the endogenous amino acid for (Tmd)Phe had severely affected ARF activity (data not shown).

Incubation of [35S]ARF-(Tmd)Phe-46 with Golgi membranes in the presence of GTPgamma S and subsequent irradiation of the membrane-bound ARF resulted in three cross-link products with estimated molecular masses of between 120 and 140 kDa (Fig. 1A, lane 2). The molecular masses of the cross-link products are in the range of several coatomer subunits (reviewed in Ref. 33), and therefore we determined whether addition of purified coatomer during the incubation of [35S]ARF-(Tmd)Phe-46 with Golgi membranes would increase the efficiency of cross-linking. As shown in Fig. 1A (lane 5 versus lane 2), a much stronger intensity of the cross-link products is observed under these conditions. In contrast to several nonspecific cross-reactivities, these three bands are strongly reduced in the presence of GDPbeta S (Fig. 1A, lane 3) or in the absence of irradiation (Fig. 1A, lane 4) or in the presence of an excess of wtARF (Fig. 1A, lane 6). ARF has to be bound to Golgi membranes for the cross-linking to occur, as an incubation in the absence of membranes lead to a complete absence of cross-link products (Fig. 1A, lane 1).


View larger version (34K):
[in this window]
[in a new window]
 
Fig. 1.   Photocross-linking of membrane-bound [35S]ARF-(Tmd)Phe-46. A, in vitro translated ARF-(Tmd)Phe46 was incubated in the absence (lane 1) or presence (all other lanes) of Golgi membranes, with GDPbeta S (lanes 3 and 7) or GTPgamma S (all other lanes), in the presence (lanes 3-6) or absence (all other lanes) of purified coatomer, in the presence of 20 µg of myristoylated ARF1 (lane 6) or in the presence of 2 mg/ml bovine brain cytosol (lanes 7-9). After incubation, the samples were centrifuged and the membranes were irradiated (except lanes 4 and 8), and membrane-bound material was analyzed by 12% SDS-PAGE (24) and autoradiography. When no membranes were present during the incubation (lane 1), 1/10th of the complete incubation was irradiated (without prior centrifugation) and was analyzed as described above. Before addition of cytosol, Golgi membranes were preincubated for 5 min at 37 °C with [35S]ARF-(Tmd)Phe-46 to prevent competition of photolabile ARF with ARF1 from cytosol. B, immunoprecipitation of membrane-bound coatomer and its individual subunits. In vitro translated ARF-(Tmd)Phe46 was bound to CHO Golgi membranes in the presence of GTPgamma S and coatomer as described in panel A, lane 5. After irradiation of membrane-bound ARF, the membranes were solubilized in detergent-buffer and the coatomer complex was immunoprecipitated using an anti-beta '-COP antibody (lane 2), or the individual coatomer subunits were immunoprecipitated after denaturation of the complex, using anti-alpha -COP antibody (lane 3), anti-beta -COP antibody (lane 4), anti-beta '-COP antibody (lane 5), and anti-gamma -COP antibody (lane 6). Immunoprecipitation with a preimmune serum is shown in lane 1. Samples were analyzed by 7.5% SDS-PAGE and subsequent autoradiography.

The specific cross-link products are also observed in the presence of high concentrations of bovine brain cytosol (a high speed supernatant from bovine brain homogenate), demonstrating the highly specific interaction between ARF and these proteins (Fig. 1, lanes 7-9). Under these conditions, Golgi membranes were preincubated for 5 min at 37 °C with [35S]ARF-(Tmd)Phe-46 before addition of cytosol in order to prevent competition of photolabile ARF1 with ARF1 from cytosol. Surprisingly, another cross-link product of ~205 kDa appears in the presence of cytosol (Fig. 1, lane 9). Subtracting the molecular mass of ARF, this protein has an apparent molecular mass in the range of about 180-185 kDa. We considered the possibility that under these circumstances, ARF might also interact with clathrin heavy chain (CHC), a protein with similar molecular mass, or with AP180, a clathrin assembly-promoting phosphoprotein, or with subunits of the adaptor protein (AP) complex, all of which are recruited to the membrane to form a clathrin coated vesicle (34-37). Immunoprecipitation with an alpha -CHC antibody did immunoprecipitate CHC from cytosol but failed to immunoprecipitate this radioactive band (data not shown). Likewise, antibodies against AP180, gamma -adaptin (a subunit of the AP-1 complex), and beta 3B (a subunit of the AP-3 complex) did immunoprecipitate their respective antigen but failed to immunoprecipitate the cross-linked product. Although we cannot exclude the possibility that the cross-link occurs at the epitope of the antibody (making it inaccessible for immunoprecipitation), these data make it unlikely that the cross-link-product is due to an interaction of ARF involved in the formation of clathrin-coated vesicles.

Immunoprecipitation studies in the absence of cytosol confirmed the presence of the cross-link products (~120-140 kDa) in the coatomer complex (Fig. 1B). An anti-coatomer antibody that immunoprecipitates native coatomer complex did immunoprecipitate all three cross-link products (Fig. 1B, lane 2). Coatomer has four subunits (alpha -, beta -, beta '-, and gamma -COP) with a molecular weight in the range in the cross-link product. Antibodies directed against each of these subunits were used to determine which subunit(s) is bound to ARF-(Tmd)Phe-46 (Fig. 1B, lanes 3-6). To this end, the samples were treated with SDS in order to dissociate coatomer before immunoprecipitation (for details see "Experimental Procedures"). Antibodies against alpha -COP (lane 3) and beta '-COP (lane 5) did not immunoprecipitate the cross-link products, whereas antibodies against beta -COP (lane 4) and gamma -COP (lane 6) efficiently immunoprecipitated two different cross-link products. The third band might be derived from beta -COP, as it is faintly seen with the beta -COP antibody (Fig. 1B, lane 4). One possibility is that more than one ARF binds to beta -COP under these conditions. Alternatively, it could be that a small fraction of ARF cross-links at a different position within beta -COP, affecting its migration.

Incubation of [35S]ARF-(Tmd)Phe-49 with isolated CHO Golgi membranes in the presence of GTPgamma S and subsequent irradiation of the membrane-bound [35S]ARF-(Tmd)Phe-49 gave a relatively complex cross-link pattern (Fig. 2A, lane 4). However, most of these cross-links are unspecific, as they also appear in the presence of GDPbeta S or in the absence of irradiation (Fig. 2A, lanes 2 and 3, respectively). Two bands at ~40 kDa are specific according to these criteria and only appear in the complete incubation (Fig. 2A, lane 4 versus lanes 2 and 3). These bands are dependent on the orientation of ARF in the membrane as they do not appear without membranes (Fig. 2A, lane 1). Several potential candidates could be involved in the formation of the cross-link product of ~40 kDa, including an interaction of ARF with the p24 family of proteins (10, 14). However, antibodies against p23 and p24 did not immunoprecipitate the cross-link products, although they did immunoprecipitate their respective antigens (data not shown). Alternatively, the cross-link products at ~40 kDa could be due to dimerization of ARF itself. This possibility cannot, of course, be tested by immunoprecipitation with alpha -ARF antibodies, as they would also immunoprecipitate ARF-(Tmd)Phe-49 together with its cross-link product. Therefore, we added increasing amounts of wtARF to the incubation of ARF-(Tmd)Phe-49 with Golgi membranes and GTPgamma S (Fig. 2B). If a cross-link exists with a protein other than ARF, this would be expected to reduce the efficiency of cross-linking as the specific activity of [35S]ARF-(Tmd)Phe-49 is reduced (see Fig. 1 and Ref. 15). However, the efficiency of the cross-linking was increased with increasing amounts of wtARF (Fig. 2B). This strongly suggests that ARF-(Tmd)Phe49 forms a dimer with ARF present on the membranes, because according to the law of mass effect, only in this case an increase of the cross-link signal is expected.


View larger version (34K):
[in this window]
[in a new window]
 
Fig. 2.   Photocross-linking of membrane-bound [35S]ARF-(Tmd)Phe-49. A, in vitro translated ARF-(Tmd)Phe49 was incubated in the absence (lane 1) or presence (all other lanes) of Golgi membranes, with GDPbeta S (lanes 2, 5, and 8) or GTPgamma S (all other lanes), in the presence (lanes 5-7) or absence (all other lanes) of purified coatomer, or in the presence of ARF-depleted cytosol (lanes 8-10). After incubation, the samples were centrifuged and the membranes were irradiated (except lanes 4 and 8) and membrane-bound material was analyzed by 12% SDS-PAGE (24) and autoradiography. When no membranes were present during the incubation (lane 1), the complete incubation was irradiated (without prior centrifugation) and was analyzed as described in the legend to Fig. 1. Cytosol was added as described in the legend to Fig. 1. B, in vitro translated ARF-(Tmd)Phe-49 was bound to CHO Golgi membranes in the presence of GTPgamma S as described in panel A (lane 4), in the absence (lane 2) or presence of 5 and 20 µg of purified recombinant myristoylated human ARF1 (lanes 3 and 4, respectively). The incubations were performed and analyzed as described in panel A. C, immunoprecipitation of membrane-bound coatomer and its individual subunits. In vitro translated ARF-(Tmd)Phe49 was bound to CHO Golgi membranes in the presence of GTPgamma S and coatomer as described in panel A. After irradiation of membrane-bound ARF, the membranes were solubilized in detergent-buffer and the coatomer complex was immunoprecipitated using an anti-beta '-COP antibody (lane 2), or the individual coatomer subunits were immunoprecipitated after denaturation of the complex, using anti-alpha -COP antibody (lane 3), anti-beta -COP antibody (lane 4), anti-beta '-COP antibody (lane 5), and anti-gamma -COP antibody (lane 6). Immunoprecipitation with a preimmune serum is shown in lane 1. Samples were analyzed by 7.5% SDS-PAGE and subsequent autoradiography.

When ARF-(Tmd)Phe-49 is incubated under standard conditions but in the presence of coatomer, an additional cross-link product appears at ~120 kDa (Fig. 2A, lane 7). This band is not observed in the presence of GDPbeta S or in the absence of irradiation (Fig. 2A, laneversus lanes 5 and 6). Addition of cytosol to the complete incubation (under conditions as described for ARF(Tmd)Phe-46) also yielded the specific cross-link products at ~40 kDa and at ~120 kDa (Fig. 2A, lane 10 versus lanes 8 and 9). The dependence on the presence of coatomer or cytosol for the ~120-kDa products to appear suggested a cross-linking of ARF-(Tmd)Phe-49 to a coatomer subunit. Indeed, immunoprecipitation of coatomer with an anti-coatomer antibody immunoprecipitated the 120-kDa cross-link product (Fig. 2C, lane 2). After dissociation with SDS, antibodies against alpha -COP (lane 3) and beta '-COP (lane 5) did not immunoprecipitate of the cross-link product, whereas antibodies against beta -COP (lane 4), and, to a much lesser extent, also gamma -COP, immunoprecipitated the cross-link product. Interestingly, both with ARF-(Tmd)Phe-46 and with ARF-(Tmd)Phe-49, in fact two bands (migrating at ~120 and 140 kDa) are immunoprecipitated with the gamma -COP antibody (Fig. 1B, lane 6; Fig. 2C, lane 6). Whereas the upper band predominates with ARF-(Tmd)Phe-46 (Fig. 1B), the lower band predominates with ARF-(Tmd)Phe-49 (Fig. 2C). As the immunoprecipitation of coatomer-subunits after dissociation of the coatomer complex is subunit-specific and no other subunits co-immunoprecipitate (15), it is likely that ARF can cross-link to two different positions of gamma -COP, affecting its migration by SDS-PAGE. Depending on the location of the photolabile analogue in ARF, one cross-link of gamma -COP prevails over the other.

ARF-(Tmd)Phe-43 was bound to Golgi membranes under the same conditions as described above for ARF-(Tmd)Phe-46 and ARF-(Tmd)Phe-49, but did not result in any detectable cross-linking to an interacting protein. This does not exclude the possibility that this site is important for interaction with other proteins, as the distance of the interaction partner with the photolabile residue is critical for cross-link efficiency (17).

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Using a site-directed photocross-linking approach, we previously identified a direct interaction between ARF and beta -COP (15). With the photolabile group at a different positions within the ARF molecule, we now find that ARF also interacts with the gamma -subunit of coatomer. Because single amino acids at position 46 as well as position 49 can interact both with beta -COP and with gamma -COP (Figs. 1 and 2), this implies that these two subunits are close neighbors within the coatomer complex. Several coatomer subcomplexes have previously been described (8, 11, 27, 31), including a beta /gamma /zeta subcomplex (9). It is important to note, however, that the cross-linking approach used here is qualitative and does not allow a quantitative determination of, e.g., the stoichiometry between ARF and coatomer. The main reason is that, in an aqueous environment, the generated carbene will react predominantly with water molecules, making cross-link yields <= 1% quite typical (38). This high reactivity, however, renders this photoprobe so specific, because a very close proximity of a protein is needed to compete with the ubiquitously abundant water molecules. Under these conditions, it can be calculated (based on the specific activity of [35S]methionine incorporated into in vitro translated ARF) that low picogram amounts of coatomer subunits are covalently bound to suppressed ARF, which does not permit quantitation of the amount of coatomer, bound to suppressed ARF (by bandshift on SDS-PAGE).

A schematic drawing of how the coatomer complex is bound to Golgi membranes is shown in Fig. 3. This model is based on the following experimental data. (i) The cytoplasmic tail of the p24 family of proteins specifically binds to coatomer (9, 10, 39). This tail contains a diphenylalanine motif and in some instances, like p23, an additional dilysine motif. The diphenylalanine motif sets these proteins apart from ER-resident proteins that contain only the dilysine ER retrieval signal (10, 40). A single binding site exists within coatomer for both dilysine retrieval motifs and the cytoplasmic domain of p23, and this site resides in gamma -COP (13). (ii) By use of site-directed photocross-linking, we have shown a direct and GTP-dependent interaction of ARF with beta -COP, which persists in COPI-coated vesicles and thus is not restricted to the budding process (15). These interactions indicate a bivalent interaction of coatomer with the Golgi membrane during vesicle formation, i.e. an anchoring of coatomer to Golgi membranes by ARF as well as by the C-terminal tails of the p24 family of proteins. (iii) The results described here demonstrate that ARF interacts with coatomer at the beta /gamma -COP interface. Thus, gamma -COP interacts both with ARF and the p24 family of proteins, indicating that the bivalent interaction occurs in close proximity of one to another. In the absence of ARF, coatomer cannot bind to Golgi membranes (6, 7), and therefore it is tempting to speculate that the initial recruitment of coatomer to Golgi membranes by ARF affects the gamma -subunit so that it subsequently allows the C-terminal tail of p24 protein(s) to bind. This binding then would lead to a conformational change of coatomer, leading to polymerization of the complex and subsequent shaping of the membrane to form a bud (41). The uncoating of COPI-coated vesicles would simply be the reversal of this process: hydrolysis of ARF-bound GTP by a GTPase-activating protein results in uncoating of COPI-coated vesicles (42). Thus, hydrolysis of ARF-bound GTP reduces the affinity of coatomer for ARF and ARF dissociates from COPI-coated vesicles. This in turn could reverse the conformational change in gamma -COP to reduce the affinity for the p24 family of proteins, resulting in dissociation from transport vesicles of the coatomer complex.


View larger version (89K):
[in this window]
[in a new window]
 
Fig. 3.   Bivalent interaction of coatomer with Golgi membranes at the beta /gamma -COP interface. For details, see "Discussion."

Together with our previous study that shows an interaction of Phe-82 in ARF with beta -COP, we have now mapped the interaction site of ARF and coatomer to a surface area of about 400 Å2, typical for protein-protein interactions. Interestingly, Ile-46, Ile-49, and Phe-82 are located on the switch 1 and 2 regions of ARF, respectively, and exactly these regions have been predicted to interact with the Sec7 domain of Arno (43), a guanine nucleotide exchange factor for ARF (44). It thus appears that one interface on ARF protein is used both for the interaction with the Sec7 domain (likely in the ARF GDP-bound form) and with the coatomer complex (in the GTP-bound form). It has been shown that N-terminally deleted ARF in its GDP-bound form can functionally interact with the Sec7 domain (45). It will be interesting to determine whether corresponding N-terminally deleted photolabile ARF proteins, mutated at the positions described in this study, can also cross-link to the Sec7 domain under these conditions.

With the photolabile amino acid residue at positions 46 and 49 of the ARF molecule, we have also found interactions with proteins other than coatomer. In the presence of cytosol, ARF-(Tmd)Phe-46 cross-links to a protein with an apparent molecular mass of ~185 kDa. Due to steric hindrance, it seems unlikely that, in addition to coatomer, a third protein binds to ARF at the same molecular interface. We consider it more likely that, under these conditions, part of the membrane-bound ARF is bound to coatomer and the other part of ARF is associated with p185. As ARF is also involved in the budding of clathrin-coated vesicles from the trans-Golgi network (34, 35), we considered the possibility that CHC, a protein with a molecular mass of ~180 kDa, was bound to ARF under these conditions. However, immunoprecipitation studies with antibodies against CHC failed to immunoprecipitate the cross-link product. Similarly, antibodies against AP180 and various subunits of the adaptor-protein complex that are recruited to the Golgi complex via ARF did not immunoprecipitate the cross-link product of ~205 kDa. As both coatomer and the AP-1 complex are recruited by ARF to the Golgi complex and the trans-Golgi network, respectively (in the presence of GTPgamma S), it is remarkable that so far we have not cross-linked one of the subunits of the adaptor protein complex. With respect to ARF involved, there are notable differences between COPI-coated vesicles and clathrin coated vesicles that bud from the Golgi. In the presence of GTPgamma S, only COPI-coated vesicles are observed, the reason for which is not clear. Possibly this guanine analogue simultaneously inhibits dynamin, a putative pinchase for clathrin-coated vesicles, which is a GTP-binding protein itself (46, 47). In addition, it has recently been reported that ARF1 only transiently activates high affinity adaptor protein complex AP-1 binding sites and that hydrolysis of ARF bound GTP can occur even before AP-1 binds (48). Finally, although ARF is involved in the recruitment of coat proteins for the formation of clathrin-coated vesicles, in contrast to COPI-coated vesicles, ARF1 is not present on coathrin-coated vesicles (48). Thus, whereas ARF is a stoichiometric component in COPI-coated vesicles, ARF seems only transiently involved in the formation of clathrin-coated vesicles and this might be the reason for the fact that we have only detected interactions with components of the COPI coat.

We are currently trying to elucidate the identity of the 205-kDa cross-linked protein by fractionation of cytosol and subsequent cross-link studies. One interesting alternative possibility is a spectrin homologue (~220 kDa), recently shown to be recruited to the Golgi membranes by ARF1 (49, 50).

Surprisingly, we have found evidence for the formation of ARF dimers on the Golgi membrane. ARF also crystallizes as a dimer (23), but it remains to be determined whether ARF dimers on Golgi membranes have the same orientation to one another as in the crystal structure. The N termini of both ARF molecules, thought to be involved in membrane anchorage of the ARF molecule, are on one interface of the crystallized dimer, theoretically allowing both N termini to interact with the membrane in this orientation. Another argument for the crystallized dimer orientation also occurring on the Golgi membranes is that according to the crystal structure, amino acid 49 in ARF is in close proximity to the other ARF molecule, i.e. in an optimal orientation for cross-linking. In this case, (Tmd)Phe-49 would result in a cross-link between ARF-(Tmd)Phe-49 (in L4) with amino acid residues 159-164 (in L12) in the second ARF molecule. If the cross-link represents an ARF homodimer, then the presence of a double band (cf. Fig. 2B) is not as easily explained, unless the two ARF molecules are different in, e.g., their myristoylation, known to affect the migration of ARF on SDS-PAGE (51). The purified recombinant myristoylated ARF added in excess is in fact a mixture of non-myristoylated and myristoylated ARF (29). Alternatively, intramolecular cross-linking may affect the migration of ARF on SDS-PAGE and might explain this phenomenon (see below). Finally, the two cross-link products at ~40 kDa might represent dimerization of different ARF isoforms. At least three different isoforms of ARF have been shown to bind to Golgi membranes (52).

In the course of these site-directed photocross-link studies, we have tried several additional positions for cross-link products. An overview of all the point mutations that we have analyzed is given in Table I. Positions 5 and 13 are present in two structural features that sets ARF apart from other GTP-binding proteins and are unique to ARF: the N-terminal alpha -helix (amino acid 2-11) and the connecting loop L1 (amino acid 10-17). These two elements are not present in small GTP-binding proteins, but are present in the Galpha subunit of heterotrimeric G proteins(23). Mutations in both these elements (Phe-5 and Phe-13) did not cross-link a protein but caused a small shift (<= 1 kDa) of the apparent molecular mass of ARF-(Tmd)Phe after irradiation. Compared with the input (membrane-bound, myristoylated ARF), it was observed that after cross-linking, the cross-link product migrated like non-myristoylated ARF, which can be separated from myristoylated ARF by high resolution SDS-PAGE. This shift is not likely due to a cross-link with membrane lipids, as treatment with several lipases did not affect the migration of the cross-link product (data not shown). It is possible that cross-linking at these positions reflects an intramolecular cross-linking with e.g. the myristoyl moiety (which lies in close proximity), causing myristoylated ARF to migrate like non-myristoylated ARF.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Summary of the mutated positions in ARF1 and their respective photocross-linked proteins
The indicated amino acid residues, secondary structures, and structural features of the positions chosen to be mutated, as shown in the table, are derived from the crystal structure of ARF1 (23). The interaction of ARF1 with beta -COP at position 82 and a possible intramolecular photocross-linking at position 13 have been described previously (15).

Likewise, introduction of (Tmd)Phe at positions Lys-142 in alpha -helix E and Tyr-154 in beta -sheet 7 of the ARF molecule did not yield protein-cross-links.

In summary, depending on the position of (Tmd)Phe in the ARF molecule, strikingly different cross-link products are obtained. The strict discrimination underlines the high specificity of the interactions observed with site-directed photocross-linking. We have identified the interface of ARF that interacts with coatomer as it is covered by Ile-46, Ile-49, and Phe-82, all on one site of the ARF molecule. With the many additional functions attributed to ARF, generation of additional photolabile ARF proteins with photocross-link residues at positions distal from the ones described here will allow one to pinpoint other partners than coatomer of this remarkable small GTP binding protein.

    ACKNOWLEDGEMENTS

We thank Dr. M. (Scotty) Robinson for the antibodies directed against clathrin heavy chain, gamma -adaptin of the AP-1 complex, and the beta 3B subunit of the AP-3 complex; Dr. E. Ungewickell for antibodies against AP180; Dr. S. Tooze for antibodies directed against gamma -adaptin (hinge region); and Daniel Gommel from the Wieland laboratory for help with the immunoprecipitation of the p24 family of proteins. Fig. 3 was originally designed and created by Drs. K. Sohn and W. Nickel.

    FOOTNOTES

* This work was supported by Deutsche Forschungsgemeinschaft grants (to F. T. W and J. B. H.) and SFB 352 (to F. T. W.), by the Swiss National Science Foundation (to J. B.), by a grant from the Human Frontiers Science Organization Program (to F. T. W.), and by a grant of the German-Israeli Foundation of Scientific Research (to X. E., F. T. W., and J. B. H.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed. Tel.: 49-6221-546758 or -544688; Fax: 49-6221-544366; E-mail: helms{at}urz.uni-heidelberg.de.

    ABBREVIATIONS

The abbreviations used are: COPI, coat protein complex type I; COP, coat protein; (Tmd)Phe, L-4'-(3-trifluoromethyl-3H-diazirin-3-yl)-phenylalanine; CHO, Chinese hamster ovary; ARF, ADP-ribosylation factor; GDPbeta S, guanosine 5'-(beta -thio)diphosphate; GTPgamma S, guanosine 5'-(gamma -thio)triphosphate; CHC, clathrin heavy chain; ER, endoplasmic reticulum; wt, wild type; AP, adaptor protein.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
  1. Rothman, J. E. (1994) Nature 372, 55-63[CrossRef][Medline] [Order article via Infotrieve]
  2. Rothman, J. E., and Wieland, F. T. (1996) Science 272, 227-234[Abstract]
  3. Donaldson, J. G., Finazzi, D., and Klausner, R. D. (1992) Nature 360, 350-352[CrossRef][Medline] [Order article via Infotrieve]
  4. Helms, J. B., and Rothman, J. E. (1992) Nature 360, 352-354[CrossRef][Medline] [Order article via Infotrieve]
  5. Randazzo, P. A., Yang, Y. C., Rulka, C., and Kahn, R. A. (1993) J. Biol. Chem. 268, 9555-9563[Abstract/Free Full Text]
  6. Donaldson, J. G., Cassel, D., Kahn, R. A., and Klausner, R. D. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 6408-6412[Abstract]
  7. Palmer, D. J., Helms, J. B., Beckers, C. J., Orci, L., and Rothman, J. E. (1993) J. Biol. Chem. 268, 12083-12089[Abstract/Free Full Text]
  8. Cosson, P., and Letourneur, F. (1994) Science 263, 1629-1631[Medline] [Order article via Infotrieve]
  9. Fiedler, K., Veit, M., Stamnes, M. A., and Rothman, J. E. (1996) Science 273, 1396-1399[Abstract]
  10. Sohn, K., Orci, L., Ravazzola, M., Amherdt, M., Bremser, M., Lottspeich, F., Fiedler, K., Helms, J. B., and Wieland, F. T. (1996) J. Cell Biol. 135, 1239-1248[Abstract]
  11. Lowe, M., and Kreis, T. E. (1995) J. Biol. Chem. 270, 31364-31371[Abstract/Free Full Text]
  12. Harter, C., Pavel, J., Coccia, F., Draken, E., Wegehingel, S., Tschochner, H., and Wieland, F. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 1902-1906[Abstract/Free Full Text]
  13. Harter, C., and Wieland, F. T. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 11649-11654[Abstract/Free Full Text]
  14. Stamnes, M. A., Craighead, M. W., Hoe, M. H., Lampen, N., Geromanos, S., Tempst, P., and Rothman, J. E. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 8011-8015[Abstract]
  15. Zhao, L. Y., Helms, J. B., Brugger, B., Harter, C., Martoglio, B., Graf, R., Brunner, J., and Wieland, F. T. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 4418-4423[Abstract/Free Full Text]
  16. Brunner, J. (1993) Chem. Soc. Rev. 22, 183-189
  17. Brunner, J. (1993) Annu. Rev. Biochem. 62, 483-514[CrossRef][Medline] [Order article via Infotrieve]
  18. Brown, H. A., Gutowski, S., Moomaw, C. R., Slaughter, C., and Sternweis, P. C. (1993) Cell 75, 1137-1144[Medline] [Order article via Infotrieve]
  19. Cockcroft, S., Thomas, G. M., Fensome, A., Geny, B., Cunningham, E., Gout, I., Hiles, I., Totty, N. F., Truong, O., and Hsuan, J. J. (1994) Science 263, 523-526[Medline] [Order article via Infotrieve]
  20. Donaldson, J. G., Kahn, R. A., Lippincott, S. J., and Klausner, R. D. (1991) Science 254, 1197-1199[Medline] [Order article via Infotrieve]
  21. Bauerfeind, R., and Huttner, W. B. (1993) Curr. Opin. Cell Biol. 5, 628-635[Medline] [Order article via Infotrieve]
  22. Randazzo, P. A. (1997) J. Biol. Chem. 272, 7688-7692[Abstract/Free Full Text]
  23. Amor, J. C., Harrison, D. H., Kahn, R. A., and Ringe, D. (1994) Nature 372, 704-708[CrossRef][Medline] [Order article via Infotrieve]
  24. Laemmli, U. K. (1970) Nature 227, 680-685[Medline] [Order article via Infotrieve]
  25. Beckers, C. J. M., and Rothman, J. E. (1992) in Reconstitution of Intracellular Transport (Rothman, J. E., ed), Vol. 219, pp. 5-12, Academic Press, Inc., San Diego
  26. Waters, M. G., Serafini, T., and Rothman, J. E. (1991) Nature 349, 248-251[CrossRef][Medline] [Order article via Infotrieve]
  27. Pavel, J., Harter, C., and Wieland, F. T. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 2140-2145[Abstract/Free Full Text]
  28. Weiss, O., Holden, J., Rulka, C., and Kahn, R. A. (1989) J. Biol. Chem. 264, 21066-21072[Abstract/Free Full Text]
  29. Helms, J. B., Palmer, D. J., and Rothman, J. E. (1993) J. Cell Biol. 121, 751-760[Abstract]
  30. Harter, C., Draken, E., Lottspeich, F., and Wieland, F. T. (1993) FEBS Lett 332, 71-73[CrossRef][Medline] [Order article via Infotrieve]
  31. Faulstich, D., Auerbach, S., Orci, L., Ravazzola, M., Wegehingel, S., Lottspeich, F., Stenbeck, G., Harter, C., Wieland, F. T., and Tschochner, H. (1996) J. Cell Biol. 135, 53-61[Abstract]
  32. Duden, R., Allan, V., and Kreis, T. (1991) Trends Cell Biol 1, 14-19
  33. Harter, C., and Wieland, F. (1996) Biochim. Biophys. Acta 1286, 75-93[Medline] [Order article via Infotrieve]
  34. Stamnes, M. A., and Rothman, J. E. (1993) Cell 73, 999-1005[Medline] [Order article via Infotrieve]
  35. Traub, L. M., Ostrom, J. A., and Kornfeld, S. (1993) J. Cell Biol. 123, 561-573[Abstract]
  36. Traub, L. M. (1997) Trends Cell Biol. 7, 43-46[CrossRef]
  37. Robinson, M. S. (1997) Trends Cell Biol. 7, 99-102[CrossRef]
  38. Brunner, J. (1989) Methods Enzymol. 172, 628-687[Medline] [Order article via Infotrieve]
  39. Dominguez, M., Dejgaard, K., Fullekrug, J., Dahan, S., Fazel, A., Paccaud, J. P., Thomas, D. Y., Bergeron, J. J., and Nilsson, T. (1998) J. Cell Biol. 140, 751-765[Abstract/Free Full Text]
  40. Fiedler, K., Kobayashi, T., Kurzchalia, T. V., and Simons, K. (1993) Biochemistry 32, 6365-6373[Medline] [Order article via Infotrieve]
  41. Reinhard, C., Harter, C., Bremser, M., Brügger, B., Sohn, K., Helms, J. G., and Wieland, F. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 1224-1228[Abstract/Free Full Text]
  42. Tanigawa, G., Orci, L., Amherdt, M., Ravazzola, M., Helms, J. B., and Rothman, J. E. (1993) J. Cell Biol. 123, 1365-1371[Abstract]
  43. Mossessova, E., Gulbis, J. M., and Goldberg, J. (1998) Cell 92, 415-423[Medline] [Order article via Infotrieve]
  44. Chardin, P., Paris, S., Antonny, B., Robineau, S., Beraud-Dufour, S., Jackson, C. L., and Chabre, M. (1996) Nature 384, 481-484[CrossRef][Medline] [Order article via Infotrieve]
  45. Paris, S., Beraud-Dufour, S., Robineau, S., Bigay, J., Antonny, B., Chabre, M., and Chardin, P. (1997) J. Biol. Chem. 272, 22221-22226[Abstract/Free Full Text]
  46. Hinshaw, J. E., and Schmid, S. L. (1995) Nature 374, 190-192[CrossRef][Medline] [Order article via Infotrieve]
  47. Roos, J., and Kelly, R. B. (1997) Trends Cell Biol. 7, 257-259[CrossRef]
  48. Zhu, Y. X., Traub, L. M., and Kornfeld, S. (1998) Mol. Biol. Cell 9, 1323-1337[Abstract/Free Full Text]
  49. Beck, K. A., Buchanan, J. A., Malhotra, V., and Nelson, W. J. (1994) J. Cell Biol. 127, 707-723[Abstract]
  50. Godi, A., Santone, I., Pertile, P., Devarajan, P., Stabach, P. R., Morrow, J. S., Di Tullio, G., Polishchuk, R., Petrucci, T. C., Luini, A., and De Matteis, M. A. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 8607-8612[Abstract/Free Full Text]
  51. Franco, M., Chardin, P., Chabre, M., and Paris, S. (1995) J. Biol. Chem. 270, 1337-1341[Abstract/Free Full Text]
  52. Tsai, S. C., Adamik, R., Haun, R. S., Moss, J., and Vaughan, M. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 9272-9276[Abstract]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.